Epigenetic silencing of monoallelically methylated miRNA loci in precancerous colorectal lesions

Oncogenesis

Volumn 2, Issue , 2013, Pages

  Menigatti, M ^a   Staiano, T ^b   Manser, C N ^c   Bauerfeind, P ^c   Komljenovic, A ^a   Robinson, M ^a   Jiricny, J ^a   Buffoli, F ^b   Marra, G ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b CREMONA HOSPITAL   (Italy)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

allele specific DNA methylation; CpG island methylation; miR 195; miR 497

Indexed keywords

BISULFITE; MICRORNA; MICRORNA 195; MICRORNA 497; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CELL STRAIN HT29; CLINICAL ARTICLE; COLORECTAL ADENOMA; COLORECTAL CANCER; CONTROLLED STUDY; CPG ISLAND; DOWN REGULATION; EPIGENETICS; FEMALE; GENE DOSAGE; GENE EXPRESSION; GENE LOCUS; GENE SEQUENCE; GENE SILENCING; HUMAN; HUMAN CELL; MALE; NUCLEOTIDE SEQUENCE; PRECANCER; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RESTRICTION MAPPING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA METHYLATION; TRANSCRIPTION INITIATION SITE;

EID: 84880560749     PISSN: None     EISSN: 21579024     Source Type: Journal    
DOI: 10.1038/oncsis.2013.21     Document Type: Article

References (62)

1. Feinberg AP, Vogelstein B. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 1983; 301: 89-92. (Pubitemid 13154475)
2. Jones PA, Baylin SB. The epigenomics of cancer. Cell 2007; 128: 683-692. (Pubitemid 46273572)
3. Lopez-Serra P, Esteller M. DNA methylation-associated silencing of tumor-suppressor microRNAs in cancer. Oncogene 2012; 31: 1609-1622.
4. Iorio MV, Croce CM. MicroRNA involvement in human cancer. Carcinogenesis 2012; 33: 1126-1133.
5. Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009; 19: 92-105.
6. Goel A, Boland CR. Epigenetics of colorectal cancer. Gastroenterology 2012.
7. Menigatti M, Truninger K, Gebbers JO, Marbet U, Marra G, Schä r P. Normal colorectal mucosa exhibits sex-and segment-specific susceptibility to DNA methylation at the hMLH1 and MGMT promoters. Oncogene 2009; 28: 899-909.
8. Menigatti M, Cattaneo E, Sabates-Bellver J, Ilinsky VV, Went P, Buffoli F et al. The protein tyrosine phosphatase receptor type R gene is an early and frequent target of silencing in human colorectal tumorigenesis. Mol Cancer 2009; 8: 124.
9. Esteller M, Tortola S, Toyota M, Capella G, Peinado MA, Baylin SB et al. Hypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status. Cancer Res 2000; 60: 129-133. (Pubitemid 30058742)
10. Suzuki H, Gabrielson E, Chen W, Anbazhagan R, van Engeland M, Weijenberg MP et al. A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat Genet 2002; 31: 141-149.
11. Sha K. A mechanistic view of genomic imprinting. Annu Rev Genomics Hum Genet 2008; 9: 197-216.
12. Das R, Hampton DD, Jirtle RL. Imprinting evolution and human health. Mamm Genome 2009; 20: 563-572.
13. Feinberg AP, Ohlsson R, Henikoff S. The epigenetic progenitor origin of human cancer. Nat Rev Genet 2006; 7: 21-33. (Pubitemid 41828945)
14. Uribe-Lewis S, Woodfine K, Stojic L, Murrell A. Molecular mechanisms of genomic imprinting and clinical implications for cancer. Expert Rev Mol Med 2011; 13: e2.
15. Luedi PP, Dietrich FS, Weidman JR, Bosko JM, Jirtle RL, Hartemink AJ. Computational and experimental identification of novel human imprinted genes. Genome Res 2007; 17: 1723-1730. (Pubitemid 351359996)
16. Tycko B. Allele-specific DNA methylation: beyond imprinting. Hum Mol Genet 2010; 19: R210-R220.
17. Liu L, Chen L, Xu Y, Li R, Du X. MicroRNA-195 promotes apoptosis and suppresses tumorigenicity of human colorectal cancer cells. Biochem Biophys Res Commun 2010; 400: 236-240.
18. Xu T, Zhu Y, Xiong Y, Ge YY, Yun JP, Zhuang SM. MicroRNA-195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells. Hepatology 2009; 50: 113-121.
19. Furuta M, Kozaki KI, Tanimoto K, Tanaka S, Arii S, Shimamura T et al. The tumorsuppressive cluster targets multiple cell-cycle regulators in hepatocellular carcinoma. PLoS One 2013; 8: e60155.
20. Soon PS, Tacon LJ, Gill AJ, Bambach CP, Sywak MS, Campbell PR et al. MiR-195 and miR-483-5p identified as predictors of poor prognosis in adrenocortical cancer. Clin Cancer Res 2009; 15: 7684-7692.
21. Flavin RJ, Smyth PC, Laios A, O'Toole SA, Barrett C, Finn SP et al. Potentially important microRNA cluster on chromosome 17p13.1 in primary peritoneal carcinoma. Mod Pathol 2009; 22: 197-205.
22. Ozsolak F, Poling LL, Wang Z, Liu H, Liu XS, Roeder RG et al. Chromatin structure analyses identify miRNA promoters. Genes Dev 2008; 22: 3172-3183.
23. Corcoran DL, Pandit KV, Gordon B, Bhattacharjee A, Kaminski N, Benos PV. Features of mammalian microRNA promoters emerge from polymerase II chromatin immunoprecipitation data. PLoS One 2009; 4: e5279.
24. Davalos V, Moutinho C, Villanueva A, Boque R, Silva P, Carneiro F et al. Dynamic epigenetic regulation of the microRNA-200 family mediates epithelial and mesenchymal transitions in human tumorigenesis. Oncogene 2012; 31: 2062-2074.
25. Liu J, Nealon JG, Weinstein LS. Distinct patterns of abnormal GNAS imprinting in familial and sporadic pseudohypoparathyroidism type IB. Hum Mol Genet 2005; 14: 95-102. (Pubitemid 40123466)
26. Robson JE, Eaton SA, Underhill P, Williams D, Peters J. MicroRNAs 296 and 298 are imprinted and part of the GNAS/Gnas cluster and miR-296 targets IKBKE and Tmed9. RNA 2012; 18: 135-144.
27. Murphy SK, Wylie AA, Coveler KJ, Cotter PD, Papenhausen PR, Sutton VR et al. Epigenetic detection of human chromosome 14 uniparental disomy. Hum Mutat 2003; 22: 92-97. (Pubitemid 36807778)
28. Kagami M, O'Sullivan MJ, Green AJ, Watabe Y, Arisaka O, Masawa N et al. The IG-DMR and the MEG3-DMR at human chromosome 14q32.2: hierarchical interaction and distinct functional properties as imprinting control centers. PLoS Genet 2010; 6: e1000992.
29. Kircher M, Bock C, Paulsen M. Structural conservation versus functional divergence of maternally expressed microRNAs in the Dlk1/Gtl2 imprinting region. BMC Genomics 2008; 9: 346.
30. Hsu SD, Lin FM, Wu WY, Liang C, Huang WC, Chan WL et al. miRTarBase: a database curates experimentally validated microRNA-target interactions. Nucleic Acids Res 2011; 39: D163-D169.
31. Xiao F, Zuo Z, Cai G, Kang S, Gao X, Li T. miRecords: an integrated resource for microRNA-target interactions. Nucleic Acids Res 2009; 37: D105-D110.
32. Dweep H, Sticht C, Pandey P, Gretz N. miRWalk-database: prediction of possible miRNA binding sites by "walking" the genes of three genomes. J Biomed Inform 2011; 44: 839-847.
33. Cattaneo E, Laczko E, Buffoli F, Zorzi F, Bianco MA, Menigatti M et al. Preinvasive colorectal lesion transcriptomes correlate with endoscopic morphology (polypoid vs. nonpolypoid). EMBO Mol Med 2011; 3: 334-347.
34. Rainier S, Johnson LA, Dobry CJ, Ping AJ, Grundy PE, Feinberg AP. Relaxation of imprinted genes in human cancer. Nature 1993; 362: 747-749. (Pubitemid 23125977)
35. Ogawa O, Eccles MR, Szeto J, McNoe LA, Yun K, Maw MA et al. Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour. Nature 1993; 362: 749-751. (Pubitemid 23125978)
36. Cui H, Horon IL, Ohlsson R, Hamilton SR, Feinberg AP. Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability. Nat Med 1998; 4: 1276-1280. (Pubitemid 28512108)
37. Cui H, Cruz-Correa M, Giardiello FM, Hutcheon DF, Kafonek DR, Brandenburg S et al. Loss of IGF2 imprinting: a potential marker of colorectal cancer risk. Science 2003; 299: 1753-1755. (Pubitemid 36337205)
38. Cui H, Onyango P, Brandenburg S, Wu Y, Hsieh CL, Feinberg AP. Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2. Cancer Res 2002; 62: 6442-6446. (Pubitemid 35364103)
39. Veronese A, Lupini L, Consiglio J, Visone R, Ferracin M, Fornari F et al. Oncogenic role of miR-483-3p at the IGF2/483 locus. Cancer Res 2010; 70: 3140-3149.
40. Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012; 487: 330-337.
41. Hao J, Zhang S, Zhou Y, Hu X, Shao C. MicroRNA 483-3p suppresses the expression of DPC4/Smad4 in pancreatic cancer. FEBS Lett 2011; 585: 207-213.
42. Nakano S, Murakami K, Meguro M, Soejima H, Higashimoto K, Urano T et al. Expression profile of LIT1/KCNQ1OT1 and epigenetic status at the KvDMR1 in colorectal cancers. Cancer Sci 2006; 97: 1147-1154. (Pubitemid 44430639)
43. Benetatos L, Hatzimichael E, Dasoula A, Dranitsaris G, Tsiara S, Syrrou M et al. CpG methylation analysis of the MEG3 and SNRPN imprinted genes in acute myeloid leukemia and myelodysplastic syndromes. Leuk Res 2010; 34: 148-153.
44. Zhang X, Gejman R, Mahta A, Zhong Y, Rice KA, Zhou Y et al. Maternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progression. Cancer Res 2010; 70: 2350-2358.
45. Cheunsuchon P, Zhou Y, Zhang X, Lee H, Chen W, Nakayama Y et al. Silencing of the imprinted DLK1-MEG3 locus in human clinically nonfunctioning pituitary adenomas. Am J Pathol 2011; 179: 2120-2130.
46. Hayward BE, Kamiya M, Strain L, Moran V, Campbell R, Hayashizaki Y et al. The human GNAS1 gene is imprinted and encodes distinct paternally and biallelically expressed G proteins. Proc Natl Acad Sci USA 1998; 95: 10038-10043. (Pubitemid 28415290)
47. Hayward BE, Bonthron DT. An imprinted antisense transcript at the human GNAS1 locus. Hum Mol Genet 2000; 9: 835-841. (Pubitemid 30162769)
48. Wei JJ, Wu X, Peng Y, Shi G, Basturk O, Yang X et al. Regulation of HMGA1 expression by microRNA-296 affects prostate cancer growth and invasion. Clin Cancer Res 2011; 17: 1297-1305.
49. Yu J, Li A, Hong SM, Hruban RH, Goggins M. MicroRNA alterations of pancreatic intraepithelial neoplasias. Clin Cancer Res 2012; 18: 981-992.
50. Vaira V, Faversani A, Dohi T, Montorsi M, Augello C, Gatti S et al. miR-296 regulation of a cell polarity-cell plasticity module controls tumor progression. Oncogene 2012; 31: 27-38.
51. Prickett AR, Oakey RJ. A survey of tissue-specific genomic imprinting in mammals. Mol Genet Genomics 2012; 287: 621-630.
52. Li D, Zhao Y, Liu C, Chen X, Qi Y, Jiang Y et al. Analysis of MiR-195 and MiR-497 expression, regulation and role in breast cancer. Clin Cancer Res 2011; 17: 1722-1730.
53. Zhang Y, Rohde C, Reinhardt R, Voelcker-Rehage C, Jeltsch A. Non-imprinted allele-specific DNA methylation on human autosomes. Genome Biol 2009; 10: R138.
54. Guo ST, Jiang CC, Wang GP, Li YP, Wang CY, Guo XY et al. MicroRNA-497 targets insulin-like growth factor 1 receptor and has a tumour suppressive role in human colorectal cancer. Oncogene 2013; 32: 1910-1920.
55. Wang X, Wang J, Ma H, Zhang J, Zhou X. Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer. Med Oncol 2012; 29: 919-927.
56. Baudis M, Cleary ML. Progenetix.net: an online repository for molecular cytogenetic aberration data. Bioinformatics 2001; 17: 1228-1229. (Pubitemid 33735351)
57. Fujimoto K, Beauchamp RD, Whitehead RH. Identification and isolation of candidate human colonic clonogenic cells based on cell surface integrin expression. Gastroenterology 2002; 123: 1941-1948. (Pubitemid 35408318)
58. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001; 29: e45.
59. Knutsen T, Padilla-Nash HM, Wangsa D, Barenboim-Stapleton L, Camps J, McNeil N et al. Definitive molecular cytogenetic characterization of 15 colorectal cancer cell lines. Genes Chromosomes Cancer 2010; 49: 204-223.
60. Gastrointest Endoscopy 2003; 58: [suppl.] S3-S27.
61. Kudo S, Rubio CA, Teixeira CR, Kashida H, Kogure E. Pit pattern in colorectal neoplasia: endoscopic magnifying view. Endoscopy 2001; 33: 367-373. (Pubitemid 32586430)
62. IARC. Editorial and consensus conference; Lyon, France; 6-9 November 1999. Genomics